Fortune 500 Pharma - Ketryx

This is some text inside of a div block.

How a Top 5 Pharma Company Took Its Software Release Cycle From Three Months to One Week

One of the world's five largest pharmaceutical companies, a Fortune 500 organization, develops GxP software applications across multiple product teams worldwide. At that scale, the ability to release fast without compromising regulatory standards is critical. Every delay has downstream consequences, and all releases must clear the traceability, documentation, and validation requirements that regulated software demands.

After implementing Ketryx, the company reduced its end-to-end release cycle from three months to one week, shortened documentation time by 70%, and eliminated more than half of its existing tooling costs. Engineering and quality teams that once spent release cycles catching up on compliance now reinvest that capacity toward advancing the product.

Impact

Three months to one week

End-to-end release cycles

70%

Reduction in documentation time

50%+

Savings in tooling costs

Industry

Pharma

Device Type

Diagnostics + SaMD

Tech Stack

Jira, GitHub

Pain Point: Engineering was not the bottleneck. Compliance was.

Code was routinely wrapped and ready to push well before the release window opened. The delay lived in compliance, but the problem wasn't processes or standards. It was the tooling meant to manage it:

Solution: Quality built into existing workflows. No migration required.

Jira, GitHub, and the rest of the engineering toolchain remained intact. Ketryx overlaid the environment around those tools, embedding compliance infrastructure and validated GxP AI without requiring a platform migration.

Business Outcome: 90% Faster Release Cycle

“I almost can't believe it, but as your website says, we did reduce our documentation time by over 90%.”

Senior Product Lead

Are You Building Medical Software?

Get started building software in minutes, not months.